Promising path found for COVID-19 therapeutics

COVID-19 therapeutics

A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein – providing a promising path for new COVID-19 therapeutics.

Led by Scott Pegan, director of UGA’s Center for Drug Discovery, the team was the first to evaluate the SARS-CoV-2 protein PLpro, known to be essential in